Beijing GoBroad Boren Hospital,part of the GoBroad Medical(Hematology)Beijing Research Center,is located in Beijing,China.The hospital specializes in the fields of hematologic oncology,Parkinson's disease,and liver cancer,as well as providing comprehensive inpatient diagnostic and treatment services,utilizing advanced technology for professional treatment.Spanning an area of 14,000 square meters,the hospital features 9 diagnostic and treatment areas,19 level-100 laminar flow wards,level-100 operating rooms and emergency wards,and is equipped with advanced Siemens 64-slice spiral CT and Siemens 3.0T MRI machines.Beyond standard clinical laboratory tests,the hospital also encompasses specialized laboratory diagnostics related to hematologic diseases,including cytology,flow cytometry,chromosome and Fluorescence In Situ Hybridization(FISH),genetic analysis(covering hematologic malignancy genes,hereditary and disease susceptibility genes,pharmacogenetics,pathogen genes,etc.),virology,and pharmacology.

The hospital has engaged international experts and scientists from Mayo Clinic International,MD Anderson Cancer Center,and others as distinguished consultants.It boasts a team of clinical physicians and diagnostic experts in various laboratory specialties related to hematology,who have rich clinical and laboratory experience,including more than 30 years of experience in the diagnosis and treatment of hematologic diseases.The hospital also features specialized interdisciplinary teams,such as hematology with infection imaging and hematology with pulmonology,to enhance the level of diagnosis and treatment of hematologic diseases,benefiting more patients.

The medical team excels in the integrated diagnosis and personalized treatment of hematologic diseases(including the selection and overall treatment strategy of chemotherapy, radiotherapy, immunotherapy, targeted therapy, demethylation,etc.).It has become a renowned center for cellular immunotherapy of hematologic tumors both domestically and internationally,particularly achieving remarkable results in CAR-T therapy for refractory and relapsed leukemia,pediatric and adult lymphoma,and myeloma.Numerous research achievements have been presented at international hematology conferences,receiving widespread acclaim from the academic community worldwide.The hematopoietic stem cell transplantation expert team has extensive experience in adult(up to 72 years old)and pediatric(as young as 1 month)transplants,having completed thousands of hematopoietic stem cell transplants with a success rate reaching international advanced levels.The transplant team has unique and successful experiences in mastering indications and timing for transplantation,selecting transplantation methods(sibling matched,unrelated,haploidentical,cord blood,syngeneic,autologous),individualizing pre-treatment plans,preventing and treating transplant complications,post-transplant immunotherapy(targeting leukemia,viruses,Fungi),bridging transplants with CAR-T,and conducting challenging haploidentical transplants and salvage transplants for refractory or relapsed hematologic tumors.